AAMI Foundation Receives $50,000 Contribution from DuPont to Expand the Dr. Michael Scholla Packaging Engineering Scholarship Fund 
How Braden Business Systems Use Auvik SaaS Management
to Identify, Secure, and Manage SaaS Sprawl About Braden Business Systems & Jon Fitzryk Since 1989, Braden Business Systems has...
Efficient Network Management: A Dive into Auvik Network Management’s Robust Features
In today's fast-paced digital world, efficient and effective network management has become more important than ever. With businesses relying heavily...
AAMI Foundation Receives $50,000 Contribution from DuPont to Expand the Dr. Michael Scholla Packaging Engineering Scholarship Fund
Arlington, Virginia--(Newsfile Corp. - November 5, 2026) - The AAMI Foundation today announced it has received a $50,000 contribution from...
Who Is the Best Facial Feminization Surgeon in the US?
The Best FFS Surgeon in the U.S. is Dr. Javad Sajan SEATTLE, WA / ACCESS Newswire / November 5, 2026...
VSee Health Announces 13 New Hospital Agreements Expected to Generate More Than $3 Million in Annual Revenue
Multi-year agreements expand iDoc subsidiary's delivery of tele-ICU services and teleradiology platform solutions HOUSTON, TX / ACCESS Newswire / November...
Sharma Oral Surgery Urges Charlotte-Area Families to Consider Wisdom Tooth Evaluation Before Age 25
Board-certified oral surgeons explain why early assessment matters, and what local patients and referring dentists should know about timing, risks,...
Managing High Blood Pressure: What Older Adults Should Know, a Q&A With Dr. Ahmed Mohiuddin
WOONSOCKET, RI / ACCESS Newswire / November 5, 2026 / Originally published on CVS Health Company NewsroomHigh blood pressure, also...
Aptevo Achieves Key Clinical Development Objective, Significantly Reducing Infusion-Related Reactions with Mipletamig in Frontline AML
Refined priming-dose regimen addresses important treatment-tolerability objective identified through FDA discussions, further strengthening mipletamig's readiness for Phase 2 developmentSubstantial reduction...
Dermata Therapeutics Highlights Media Recognition of Tome Skincare Following Commercial Launch
- Tome Skincare featured in Cosmopolitan, Women's Wear Daily, AIR MAIL, and Thingtesting highlights Tome's growing recognition among leading beauty...
BioAdaptives to Acquire Xycota Biosciences to Pursue the Potential of At Home Psilocybin Treatment
Xycota's lead program aims to deliver clinical benefit from low-dose psilocybin without hallucinogenic effects, with mild PTSD as its initial...
Cosmos Health’s CosmoFarm Begins Commissioning New Automated Order-Processing and Vehicle-Loading Infrastructure, Advancing Capacity That Could Support Over $120 Million in Annual Revenue
New order-processing line: automated handling cell and roller conveyor now being commissioned at CosmoFarm's distribution center in Peristeri, Athens, designed...
BetterLife Pharma Appoints Henry Chow, CPA, CA, to Board of Directors
Tony Pullen steps down from the Board and will continue with the Company as an advisorVancouver, British Columbia--(Newsfile Corp. -...
Apptly Health Completes National Rebrand from UberDoc; Launches Paid Physician and Healthcare Partner Memberships
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (OTCQB: APTHF) (the "Company" or...
Link Biologics completes IND-enabling preclinical programme for LB001, a first-in-class novel therapy for dry eye disease
Completion of key IND-enabling activities represents a major development milestone for LB001IND submission remains on track for Q1 2027, followed...
ArrayPatch Completes Oversubscribed €3.2 Million Seed Financing to Advance Next-Generation Microneedle Therapeutics
CORK, Ireland, Nov. 05, 2026 (GLOBE NEWSWIRE) -- ArrayPatch Ltd (“ArrayPatch”), a biotech company developing innovative microneedle-based therapeutics, today announced...
Alethio Therapeutics Raises $90 Million (£67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms
Alethio Therapeutics Rohit Batta, CEO Series A financing co-led by Sofinnova Partners and RA Capital alongside founding investor Oxford Science...
Ethris Reports Positive Topline Phase 2a Data for Nasal mRNA Candidate ETH47 in Asthma Patients Challenged with Rhinovirus
40-fold lower virus load compared to placebo on Day 2, at the peak of viral replicationExposure-response relationship observed, with greater...
9M 2026: Novonesis delivered 7% organic sales growth, confirming full-year outlook
COPENHAGEN, Denmark – November 5, 2026. Novonesis delivered strong Q3 sales leading to 9M financial results at 7% organic sales...
T-Therapeutics announces oversubscribed $133 million Series B financing to achieve clinical proof-of-concept for first-in-class TCR bispecific therapies in cancer and autoimmune disease
$133 million Series B financing co-led by new investors Advent Life Sciences and British Business Bank, with additional new investments...
Interim report 9M 2026
Strong Q3 sales leading to 9M at 7% organic sales growth and adj. EBITDA margin of 37.9%. 2026 outlook confirmed:...
ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business
Egetis Therapeutics’ lead asset, EMCITATE®, is the first and only approved treatment in U.S. and Europe for peripheral thyrotoxicosis associated...
Siemens Healthineers to Rebrand In Vitro Diagnostics Business as Olyrian Diagnostics
Siemens Healthineers announced today it has initiated the carve-out process for its in vitro diagnostics business Olyrian Diagnostics Siemens Healthineers...